GPCR News
Diversity and specificity in location-based signaling outputs of neuronal GPCRs
Posttranslational modifications in GPCR internalization
Molecular basis for ligand modulation of the cannabinoid CB 1 receptor
In vivo detection of GPCR-dependent signaling using fiber photometry and FRET-based biosensors
GRK2 in cardiovascular disease and its potential as a therapeutic target
Targeting CXCR1 and CXCR2 receptors in cardiovascular diseases
TAS2R supports odontoblastic differentiation of human dental pulp stem cells in the inflammatory...
Adenosine receptor signalling in Alzheimer's disease
Structures of β 1-adrenergic receptor in complex with Gs and ligands of different efficacies
Exploring pharmacological inhibition of G q/11 as an analgesic strategy
Anatomy of a partnership: Cancer Research UK teams up with Sosei Heptares
Fluorescent Ligands Targeting Intracellular Allosteric Binding Site of the Chemokine Receptor CCR2
Karuna Therapeutics Announces Positive Results from Phase 3 EMERGENT-2 Trial of KarXT in...
Synthesis and characterization of an orally bioavailable small molecule agonist of the apelin recept
Luciferase-based GloSensor™ cAMP assay: Temperature optimization and application to cell-based kinet
Tracking receptor motions at the plasma membrane reveals distinct effects of ligands on CCR5...
4GPCRnet, September 26-29, 2022. Leipzig, Germany
Discovery On Target, October 17-20, 2022, Boston, USA
Anosmin 1 N-terminal domains modulate prokineticin receptor 2 activation by prokineticin 2
GPCR kinases generate an APH1A phosphorylation barcode to regulate amyloid-β generation